Marex Group’s Gilead Sciences GILD Stock Holding History

Marex Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$318K	Sell	2,515 -4,306	-63%	-$567K	﹤0.01%	840
2026 Q1	$951K	Buy	6,821 +1,110	+19%	+$155K	0.01%	447
2025 Q4	$701K	Buy	5,711 +755	+15%	+$91.8K	﹤0.01%	475
2025 Q3	$550K	Buy	+4,956	New	+$563K	﹤0.01%	473
2025 Q2	–	Sell	-2,086	Closed	-$234K	–	766
2025 Q1	$234K	Buy	+2,086	New	+$215K	﹤0.01%	540
2024 Q4	–	Sell	-2,988	Closed	-$251K	–	739
2024 Q3	$251K	Sell	2,988 -2,020	-40%	-$154K	0.01%	423
2024 Q2	$344K	Buy	5,008 +911	+22%	+$60.8K	0.01%	384
2024 Q1	$300K	Sell	4,097 -318,635	-99%	-$24.5M	0.01%	330
2023 Q4	$26.1M	Buy	+322,732	New	+$25.1M	1.03%	19
2023 Q3	–	Sell	-35,000	Closed	-$2.7M	–	236
2023 Q2	$2.7M	Buy	+35,000	New	+$2.79M	0.49%	44
2023 Q1	–	Sell	-7,100	Closed	-$605K	–	285
2022 Q4	$605K	Buy	+7,100	New	+$562K	0.09%	151

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marex Group's GILD Position: Q2 2026 in Review

Marex Group reduced its Gilead Sciences (GILD) stake by 63% in Q2 2026, selling an estimated $567K and leaving 2,515 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Marex Group first reported a position in GILD in Q4 2022 and has held it in 11 quarters since. The position peaked at $26.1M in Q4 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Marex Group held 2,515 shares of Gilead Sciences worth $318K as of Q2 2026.
Marex Group sold 4,306 Gilead Sciences shares in Q2 2026, an estimated $567K.
Gilead Sciences made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #840 holding.
Marex Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 11 quarters since.
Marex Group's Gilead Sciences position peaked at $26.1M in Q4 2023.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.